Clinical Trial Update: TMC435-TiDP16-C117: The Effect of TMC435 on the Results of Electrocardiograms (Electric Recording of the Heart) in Healthy Volunteers [Phase 1]

View source ↗

Summary

A Phase 1 study examining whether TMC435 affects electrocardiogram results in healthy volunteers to assess cardiac safety.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• TMC435

Snippet

Sponsor: Tibotec Pharmaceuticals, Ireland | Conditions: Hepatitis C | Phase 1 | Status: COMPLETED